Go Back to Match Results for ""

A study of Hematopoietic Stem Cell Transplantation (HSCT) in Non-Malignant Disease using a Reduced-Intensity preparatory regime with Campath-1H Fludarabine and Melphalan
Study Overview
The overall purpose of this research is to treat diseases that are not cancer but are improved by bone marrow transplantation.
Study Description
The overall purpose of this research is to treat diseases that are not cancer but are improved by bone marrow transplantation.
Additional Information
- IRB Number: 1010002807
- Research Study Identifier: TX782
- Principal Investigator: Paul Haut, MD
Recruitment Status
OpenContact the research team to learn more about this study.
Fields marked with asterisk (*) are required